749660--3/22/2007--ICAD

related topics

{stock, price, share}

{product, liability, claim}

{customer, product, revenue}

{control, financial, internal}

{cost, regulation, environmental}

{product, market, service}

{acquisition, growth, future}

{stock, price, operating}

{product, candidate, development}

{provision, law, control}

{property, intellectual, protect}

{personnel, key, retain}

{regulation, government, change}

We have incurred significant losses since inception and there can be no assurance that we will be able to achieve and sustain future profitability. A limited number of customers account for a significant portion of our total revenues. The loss of a principal customer could seriously hurt our business. Our business is dependent upon future market growth and acceptance of digital mammography systems and other digital computer aided detection (CAD) products. Our quarterly operating and financial results and our gross margins are likely to fluctuate significantly in future periods. We may need additional financing to implement our strategy and expand our business. Changes in reimbursement procedures by Medicare or other third-party payers may adversely affect our business. We cannot be certain of the future effectiveness of our internal controls over financial reporting or the impact of the same on our operations or the market price for our common stock. Our business is subject to The Health Insurance Portability and Accountability Act of 1996, and changes to or violations of these regulations could negatively impact our revenues. We do not anticipate paying cash dividends on our common stock. The markets for many of our products are subject to changing technology. We depend upon a limited number of suppliers and manufacturers for our products, and certain components in our products may be available from a sole or limited number of suppliers. make it more difficult for a third party to acquire us, discourage a takeover and adversely affect existing stockholders price of our common stock has been which could reduce the market price of our common stock Our products and manufacturing facilities are subject to extensive regulation with potentially significant costs for compliance. We may not be able to obtain regulatory approval for any of the other products that we may consider developing. Our products may be recalled even after we have received FDA or other governmental approval or clearance. We rely on intellectual property and proprietary rights to maintain our competitive position and may not be able to protect these rights. We may be exposed to significant product liability for which we may not be able to procure sufficient insurance coverage. Our future prospects depend on our ability to retain current key employees and attract additional qualified personnel. We distribute our products in highly competitive markets. Future sales of shares of our common stock our ability to raise additional capital.

Full 10-K form ▸

749660--3/22/2007--ICAD_INC